글로벌 위풍선 시술 시장 – 2023-2030

Global Gastric Balloon Procedures Market - 2023-2030

상품코드DMMD64
발행기관DataM Intelligence
발행일2023.02.01
페이지 수200 Pages
포맷PDF + EXCEL
커버리지Global

6,525,00011,775,000

보고서 요약(국문)

시장 개요
전 세계 위풍선 시술 시장 규모는 2023년 4,945만 달러였으며, 2030년까지 연평균 12.4% 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
위풍선 시술(내시경 위내 풍선 삽입술)은 환자의 위장에 1~3개의 실리콘 풍선을 수개월 동안 삽입하여 과체중을 약 30% 감량하고 환자의 건강 상태를 개선하는 시술입니다.
시장 동향
전 세계 위풍선 시술 시장 성장을 견인하는 주요 요인은 비만으로 인한 제2형 당뇨병 발병률 증가, 건강 및 체형에 대한 인식 제고, 전 세계적인 비만 인구 증가, 인식 개선 활동 강화, 기술 발전으로 인한 신제품 출시 등입니다.

전 세계적으로 건강과 체형에 대한 인식이 높아지고 비만 인구가 증가함에 따라 새로운 제품 개발이 활발해지고 있으며, 이러한 추세가 시장 성장을 견인할 것으로 예상됩니다.
위풍선 시술 시장은 건강과 체형에 대한 인식 증가, 기술 발전, 고령 인구 증가, 연구 개발 투자 증가, 비만으로 인한 제2형 당뇨병 환자 증가, 최신 기술을 활용한 신제품 개발, 그리고 신흥 시장의 의료 인프라 개선 등에 힘입어 성장하고 있습니다.
위풍선 시술은 체중 감량을 위해 널리 사용되고 있습니다. 이러한 기기의 사용이 증가함에 따라 정부의 지원과 자금 투입도 늘어나고 있습니다. 이러한 자금은 단일, 이중, 삼중 위풍선과 같은 위풍선 제품 생산에 도움이 될 것입니다. 비만 인구 증가로 인해 전 세계적으로 위풍선 시장이 성장하고 있습니다. 또한, 주요 업체들의 기술적으로 진보된 제품 출시 역시 시장 성장에 중요한 역할을 할 것으로 예상됩니다.

다양한 신제품 출시, 연구 조사, 그리고 위풍선 시술 관련 인식 제고 활동이 시장 성장에 기여하고 있습니다. 2022년 5월 26일, 의사가 주도하는 대사 건강 및 체중 감량 솔루션 기업인 ReShape Lifesciences는 가상 진료 종합 서비스 제공업체인 OpenLoop와 의사 주도의 전국적인 원격 의료 체중 감량 코칭 솔루션 구축 계약을 체결했다고 발표했습니다.
하지만 위풍선 사용과 관련된 위험 및 안전 문제는 시장 성장을 저해할 것으로 예상됩니다.
특히 위풍선 시술에 사용되는 실리콘 풍선의 승인에 대한 엄격한 규정이 위풍선 시술 시장 성장을 저해하는 주요 요인입니다. 높은 시술 비용 또한 성장을 제한하는 요소입니다.
위풍선 또는 카테터 사용과 관련된 위험 및 안전 문제는 시장 성장을 저해할 가능성이 높습니다. 식염수나 가스로 채워진 위풍선은 막힘을 유발할 수 있으며, 이 경우 기기 제거를 위한 수술이 필요할 수 있습니다. 다른 위험으로는 급성 췌장염, 과팽창 및 위벽 궤양이 있습니다.
COVID-19 영향 분석
팬데믹은 전 세계 재정 전망, 운영 및 위기 대응 전략에 부정적인 영향을 미쳤습니다. COVID-19 발생은 의료 산업에 심각한 영향을 미쳤습니다. 위풍선 시술 시장은 COVID-19로 인해 막대한 손실을 입었습니다. 주요 제조업체들은 다양한 연구 및 임상 시험을 시작했습니다. 전 세계적으로 다양한 계획, 제품 출시, 협력 및 합병이 진행되어 시장 성장을 촉진하고 있습니다. 예를 들어, 2022년 10월 31일, 의사가 주도하는 대사 건강 및 체중 감량 솔루션 기업인 ReShape Lifesciences는 국제 비만 및 대사 질환 수술 연맹(IFSO)과 미국 대사 및 비만 수술 학회(ASMBS)가 위밴드 시술을 포함한 대사 및 비만 수술에 대한 새로운 가이드라인을 업데이트했다고 발표했습니다.

세그먼트 분석
단일 위풍선 세그먼트는 예측 기간(2022-2029년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
단일 위풍선 세그먼트는 전 세계 위풍선 시술 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 전 세계 위풍선 시술 시장은 제품 유형에 따라 단일 위풍선, 이중 위풍선, 삼중 위풍선으로 구분됩니다. 단일 위풍선 세그먼트는 전 세계적으로 단일 위풍선을 이용한 시술 건수 증가, 기술 발전 및 신제품 출시로 인해 가장 큰 시장 점유율을 확보하고 있습니다.
단일 위풍선은 위풍선 시술에 가장 일반적으로 사용되는 풍선으로, 삽입이 간편합니다. 이 시술은 의사가 카테터를 위장에 삽입한 후 풍선에 가스 또는 생리식염수를 채워 넣는 일회성 시술입니다. 이를 통해 환자는 소량의 음식 섭취 후에도 포만감을 느낄 수 있습니다. 풍선은 삽입 후 6개월 후에 제거됩니다. 이 모든 시술은 내시경의 직접적인 감독 하에 진행됩니다. 단일 위풍선을 이용한 시술은 시행하기 쉽습니다.

규제 승인 증가, 기술 발전, 신제품 출시, 연구/임상 시험 연구 등이 시장 성장을 견인하고 있습니다. 예를 들어, 비만 및 위장 수술용 최소 침습 의료기기 공급업체인 아폴로 엔도서저리(Apollo Endosurgery, Inc.)는 2022년 11월 21일, BIB, OverStitch 시스템, Orbera 365 위내 풍선 등 기존 제품에 대해 유럽 의료기기 규정(MDR)에 따른 CE 마크 획득에 성공했다고 발표했습니다. 영국 표준 협회(British Standards Institute)에서 발급한 이 새로운 인증서는 5년간 유효합니다.
지역 분석
북미는 전 세계 위풍선 시술 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미는 인구 규모, 우수한 의료 인프라, 높은 소득 수준을 바탕으로 전 세계 위풍선 시술 시장을 주도하고 있습니다. 미국 내 의료비 지출 증가로 인해 시장은 예측 기간 동안 비교적 완만한 성장세를 보일 것으로 예상됩니다. 시장 규모의 상당 부분은 높은 의료비 지출에 기인합니다.

의료비 지출 증가와 사람들의 인식 제고 또한 이 지역 시장 성장에 기여하고 있습니다. 내시경 또는 비내시경 방식의 체중 감량용 위풍선 시술법 발전, 이 지역 내 제약 회사 설립 증가, 정부 승인 확대, 그리고 주요 업체들의 진출은 위풍선 시술 시장 성장에 기여하고 있습니다.
또한, 신제품 출시 증가도 시장 성장의 주요 요인입니다. 이 지역에서는 많은 주요 개발, 기술 발전, 협력 및 계약이 활발히 진행되고 있습니다. 예를 들어, 2022년 11월 29일, 비만 및 위장 수술용 최소 침습 의료기기 공급업체인 아폴로 엔도서저리(Apollo Endosurgery, Inc.)는 의료 기술 공급업체인 보스턴 사이언티픽(Boston Scientific Corporation)과의 인수 합병 계약을 발표했습니다.
경쟁 환경
위풍선 시술 시장은 국내외 기업들이 경쟁하는 비교적 경쟁적인 시장입니다. Apollo Endosurgery Inc., ReShape Lifesciences, Inc., LEXEL S.R.L., Medispar C.V.B.A, Allurion, Helioscopie Medical Implants, Districlass Médical, ENDALIS, Accel Medical, Silimed, Inc. 등을 비롯한 주요 기업들이 제품 출시, 인수합병, 파트너십, 협력 등 다양한 성장 전략을 통해 시장 성장에 기여하고 있습니다. 예를 들어, 체중 감량 솔루션 제공업체인 ReShape Lifesciences Inc.는 2021년 6월 16일 Obalon Therapeutics와의 합병을 완료했다고 발표했습니다. Obalon은 ReShape Lifesciences Inc.로 사명을 변경했으며, 합병된 회사의 보통주는 "RSLS"라는 티커 심볼로 거래를 시작할 예정입니다.
리쉐이프 라이프사이언스(ReShape Lifesciences, Inc.)
개요: 리쉐이프 라이프사이언스는 비만 및 대사 질환의 치료와 관리를 위한 통합 제품 및 서비스 포트폴리오를 제공하는 대사 건강 및 체중 감량 솔루션 제공 기업입니다.
제품 포트폴리오:
오발론(Obalon) 풍선 시스템: 체중 감량을 위해 특별히 개발된 최초이자 유일한 FDA 승인 가스 주입식 삼킬 수 있는 풍선 시스템입니다.
글로벌 위풍선 시술 시장 보고서는 약 45개 이상의 시장 데이터 표, 40개 이상의 그림 및 200페이지(약) 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global gastric balloon procedures market size was valued at US$ 49.45 million in 2023 and is estimated to reach US$ XX million by 2030, growing at a CAGR of 12.4% during the forecast period (2023-2030).
Gastric balloon procedures also called an endoscopic intragastric balloon, is the procedure of inserting 1 to 3 silicon balloons in the stomach of the patient for a few months so that they lose around 30% of excess weight, thereby improving the health condition of the patient.
Market Dynamics
The major factors driving the global gastric balloon procedures market are the rising demand for gastric balloon procedures owing to increasing incidences of type-2diabetes which is mainly caused due to obesity, increasing consciousness on fitness and structure, growing obese population across the globe,, surging awareness initiatives, advancements in technologies leading to novel product launches.
The increasing consciousness on fitness and structure and growing obese population across the globe leading to the development of novel products are expected to drive the market’s growth.
The gastric balloon procedures market is driven by increasing consciousness on fitness and structure, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of type-2 diabetes cases which is mainly caused due to obesity and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.
The gastric balloon procedures are used widely for weight loss. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce gastric balloon products such as single, dual and triple gastric balloons. The market for these gastric balloons is increasing worldwide due to the enhanced number of people suffering from obesity. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market’s growth.
Various novel product launches, research studies, and rising awareness initiatives related to these gastric balloon procedures medications contribute to the market’s growth. in May 26, 2022, ReShape Lifesciences, a physician-led metabolic health and weight loss solutions company announced its agreement with OpenLoop, virtual care full-stack delivery services provider, to arrange a physician-led, nationwide, telehealth solution for virtual weight loss coaching.
Risks and safety concerns associated with the use of these gastric balloons are expected to hamper the market’s growth.
However strict rules and regulations for the approval of the silicone balloons utilized for procedure of gastric balloon placement is the major factor hindering the growth of the gastric balloon procedures market. High costs of these procedures is also a limiting factor.
The risks and safety concerns associated with the use of these gastric balloons or catheters are likely to hinder the growth. High risk related to these gastric balloons that are filled with either saline or gas can cause a blockage which requires surgery for the removal of device. Other risks are acute pancreatitis, over-inflation and ulcers in the stomach wall.
COVID-19 Impact Analysis
The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The gastric balloon procedures market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market’s growth. For instance, in October 31, 2022, ReShape Lifesciences, a physician-led metabolic health and weight loss solutions company announced that the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) and the American Society for Metabolic and Bariatric Surgery (ASMBS) have issued novel guidelines that have been updated for Metabolic and Bariatric Surgery which include the Lap-Band.
Segment Analysis
The single gastric balloon segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The single gastric balloon segment is the highest market holder in the global gastric balloon procedures market. The global gastric balloon procedures market is segmented based on product type as single gastric balloon, dual gastric balloon and triple gastric balloon. The single gastric balloon segment is the largest market shareholder due to its increasing number of procedures utilizing single gastric ballons globally, increasing technological advancements and novel product launches.
Single gastric balloon is the most commonly used balloon for gastric balloon procedures which is easy to insert as this one time procedure where the doctor will place the catheter inside the stomach and then fill the balloon with either gas or saline water so the person may feel full after eating small amount of food. This balloon will then be removed after 6 months of placement. This whole procedure is done under direct supervision of endoscopy. The procedure involving single gastric balloon is easy to perform.
The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market’s growth. For instance, in November 21, 2022, Apollo Endosurgery, Inc., a minimally invasive medical devices provider for bariatric and gastrointestinal procedures, announced about its successful transition under the European Medical Device Regulation (MDR) of legacy products including for the BIB, OverStitch Systems and Orbera 365 intragastric balloons to CE Mark. The novel certificates were issued by British Standards Institute and are valid for five years.
Geographical Analysis
North America holds the largest market share in the global gastric balloon procedures market.
North America dominates the global gastric balloon procedures market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market’s significant size is attributed to the high medical expenditure.
Increasing expenditure on healthcare and raising awareness among people is also contributing to the market’s growth in this region. Advancement of gastric balloon procedures such as endoscopic or non-endoscopic like swallowing for weight loss, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the gastric balloon procedures market.
Moreover, the growing number of product launches is responsible for the market’s growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in November 29, 2022, Apollo Endosurgery, Inc., a minimally invasive medical device provider company for bariatric and gastrointestinal procedures, announced about entering into an acquisition merger agreement with Boston Scientific Corporation, a medical technology provider company.
Competitive Landscape
The gastric balloon procedures market is moderately competitive with local and global companies’ presence. Apollo Endosurgery Inc., ReShape Lifesciences, Inc., LEXEL S.R.L., Medispar C.V.B.A, Allurion, Helioscopie Medical Implants, Districlass Médical, ENDALIS, Accel Medical, Silimed, Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in June 16, 2021, ReShape Lifesciences Inc., a weight-loss solutions provider announced its completion of the announced merger with Obalon Therapeutics. Obalon’s name is changed to ReShape Lifesciences Inc. and company's combined common stock will initiate trading under the ticker symbol "RSLS".
ReShape Lifesciences, Inc.
Overview: ReShape Lifesciences is a metabolic health and weight loss-solutions provider company, providing an integrated portfolio of products and services that treat and manage obesity and metabolic disorders.
Product Portfolio:
Obalon Balloon System: It is the first and only gas-filled, swallowable, FDA-approved balloon system specially developed for weight-loss.
The global gastric balloon procedures market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing consciousness on fitness and structure
4.1.1.2. Growing obese population
4.1.2. Restraints:
4.1.2.1. Safety concerns regarding the use of gastric balloons
4.1.2.2. High cost
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1 Porter's Five Forces Analysis
5.2 Supply Chain Analysis
5.3 Pricing Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Single Gastric Balloon*
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Dual Gastric Balloon
7.4. Triple Gastric Balloon
8. By Procedure
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
8.1.2. Market Attractiveness Index, By Placement
8.2. Endoscopic *
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Non-Endoscopic
9. By Filling
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
9.1.2. Market Attractiveness Index, By Filling
9.2. Saline-Filled Gastric Balloon*
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Gas-Filled Gastric Balloon
10. By Volume
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
10.1.2. Market Attractiveness Index, By Volume
10.2. Adjustable Gastric Balloon *
10.2.1. Introduction
10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Non-Adjustable Gastric Balloon
11. By End-User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.1.2. Market Attractiveness Index, By End-User
11.2. Hospitals *
11.2.1. Introduction
11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
11.3. Ambulatory Surgical Centers
11.4. Clinics
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Placement
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Filling
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Volume
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
13. Competitive Landscape
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Products Benchmarking
13.4. List of Key Companies to Watch
14. Company Profiles
14.1. Apollo Endosurgery Inc. *
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. ReShape Lifesciences, Inc.
14.3. LEXEL S.R.L.
14.4. Medispar c.v.b.a.
14.5. Allurion
14.6. Helioscopie Medical Implants
14.7. Districlass Médical
14.8. ENDALIS
14.9. Accel Medical
14.10. Silimed, Inc.
LIST NOT EXHAUSTIVE
15. Global Gastric Balloon Procedures Market – DataM
15.1. Appendix
15.2. About Us and Medications
15.3. Contact Us

언급된 주요 기업들

Apollo Endosurgery Inc., ReShape Lifesciences, Inc., LEXEL S.R.L., Medispar c.v.b.a., Allurion, Helioscopie Medical Implants, Districlass Médical, ENDALIS, Accel Medical, Silimed, Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Gastric Balloon Procedure Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table 2 Global Gastric Balloon Procedure Market Value, By Procedure, 2023, 2027 & 2031 ($ Million)

Table 3 Global Gastric Balloon Procedure Market Value, By Filling, 2023, 2027 & 2031 ($ Million)

Table 4 Global Gastric Balloon Procedure Market Value, By Volume, 2023, 2027 & 2031 ($ Million)

Table 5 Global Gastric Balloon Procedure Market Value, By End-User, 2023, 2027 & 2031 ($ Million)

Table 6 Global Gastric Balloon Procedure Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 7 Global Gastric Balloon Procedure Market Value, By Product Type, 2023, 2027 & 2031 ($ Million)

Table 8 Global Gastric Balloon Procedure Market Value, By Product Type, 2022-2031 ($ Million)

Table 9 Global Gastric Balloon Procedure Market Value, By Procedure, 2023, 2027 & 2031 ($ Million)

Table 10 Global Gastric Balloon Procedure Market Value, By Procedure, 2022-2031 ($ Million)

Table 11 Global Gastric Balloon Procedure Market Value, By Filling, 2023, 2027 & 2031 ($ Million)

Table 12 Global Gastric Balloon Procedure Market Value, By Filling, 2022-2031 ($ Million)

Table 13 Global Gastric Balloon Procedure Market Value, By Volume, 2023, 2027 & 2031 ($ Million)

Table 14 Global Gastric Balloon Procedure Market Value, By Volume, 2022-2031 ($ Million)

Table 15 Global Gastric Balloon Procedure Market Value, By End-User, 2023, 2027 & 2031 ($ Million)

Table 16 Global Gastric Balloon Procedure Market Value, By End-User, 2022-2031 ($ Million)

Table 17 Global Gastric Balloon Procedure Market Value, By Region, 2023, 2027 & 2031 ($ Million)

Table 18 Global Gastric Balloon Procedure Market Value, By Region, 2022-2031 ($ Million)

Table 19 North America Gastric Balloon Procedure Market Value, By Product Type, 2022-2031 ($ Million)

Table 20 North America Gastric Balloon Procedure Market Value, By Procedure, 2022-2031 ($ Million)

Table 21 North America Gastric Balloon Procedure Market Value, By Filling, 2022-2031 ($ Million)

Table 22 North America Gastric Balloon Procedure Market Value, By Volume, 2022-2031 ($ Million)

Table 23 North America Gastric Balloon Procedure Market Value, By End-User, 2022-2031 ($ Million)

Table 24 North America Gastric Balloon Procedure Market Value, By Country, 2022-2031 ($ Million)

Table 25 South America Gastric Balloon Procedure Market Value, By Product Type, 2022-2031 ($ Million)

Table 26 South America Gastric Balloon Procedure Market Value, By Procedure, 2022-2031 ($ Million)

Table 27 South America Gastric Balloon Procedure Market Value, By Filling, 2022-2031 ($ Million)

Table 28 South America Gastric Balloon Procedure Market Value, By Volume, 2022-2031 ($ Million)

Table 29 South America Gastric Balloon Procedure Market Value, By End-User, 2022-2031 ($ Million)

Table 30 South America Gastric Balloon Procedure Market Value, By Country, 2022-2031 ($ Million)

Table 31 Europe Gastric Balloon Procedure Market Value, By Product Type, 2022-2031 ($ Million)

Table 32 Europe Gastric Balloon Procedure Market Value, By Procedure, 2022-2031 ($ Million)

Table 33 Europe Gastric Balloon Procedure Market Value, By Filling, 2022-2031 ($ Million)

Table 34 Europe Gastric Balloon Procedure Market Value, By Volume, 2022-2031 ($ Million)

Table 35 Europe Gastric Balloon Procedure Market Value, By End-User, 2022-2031 ($ Million)

Table 36 Europe Gastric Balloon Procedure Market Value, By Country, 2022-2031 ($ Million)

Table 37 Asia-Pacific Gastric Balloon Procedure Market Value, By Product Type, 2022-2031 ($ Million)

Table 38 Asia-Pacific Gastric Balloon Procedure Market Value, By Procedure, 2022-2031 ($ Million)

Table 39 Asia-Pacific Gastric Balloon Procedure Market Value, By Filling, 2022-2031 ($ Million)

Table 40 Asia-Pacific Gastric Balloon Procedure Market Value, By Volume, 2022-2031 ($ Million)

Table 41 Asia-Pacific Gastric Balloon Procedure Market Value, By End-User, 2022-2031 ($ Million)

Table 42 Asia-Pacific Gastric Balloon Procedure Market Value, By Country, 2022-2031 ($ Million)

Table 43 Middle East & Africa Gastric Balloon Procedure Market Value, By Product Type, 2022-2031 ($ Million)

Table 44 Middle East & Africa Gastric Balloon Procedure Market Value, By Procedure, 2022-2031 ($ Million)

Table 45 Middle East & Africa Gastric Balloon Procedure Market Value, By Filling, 2022-2031 ($ Million)

Table 46 Middle East & Africa Gastric Balloon Procedure Market Value, By Volume, 2022-2031 ($ Million)

Table 47 Middle East & Africa Gastric Balloon Procedure Market Value, By End-User, 2022-2031 ($ Million)

Table 48 Apollo Endosurgery Inc.: Overview

Table 49 Apollo Endosurgery Inc.: Product Portfolio

Table 50 Apollo Endosurgery Inc.: Key Developments

Table 51 ReShape Lifesciences, Inc.: Overview

Table 52 ReShape Lifesciences, Inc.: Product Portfolio

Table 53 ReShape Lifesciences, Inc.: Key Developments

Table 54 LEXEL S.R.L.: Overview

Table 55 LEXEL S.R.L.: Product Portfolio

Table 56 LEXEL S.R.L.: Key Developments

Table 57 Medispar C.V.B.A: Overview

Table 58 Medispar C.V.B.A: Product Portfolio

Table 59 Medispar C.V.B.A: Key Developments

Table 60 Allurion: Overview

Table 61 Allurion: Product Portfolio

Table 62 Allurion: Key Developments

Table 63 Helioscopie Medical Implants: Overview

Table 64 Helioscopie Medical Implants: Product Portfolio

Table 65 Helioscopie Medical Implants: Key Developments

Table 66 Districlass Médical: Overview

Table 67 Districlass Médical: Product Portfolio

Table 68 Districlass Médical: Key Developments

Table 69 ENDALIS: Overview

Table 70 ENDALIS: Product Portfolio

Table 71 ENDALIS: Key Developments

Table 72 Accel Medical: Overview

Table 73 Accel Medical: Product Portfolio

Table 74 Accel Medical: Key Developments

Table 75 Silimed, Inc.: Overview

Table 76 Silimed, Inc.: Product Portfolio

Table 77 Silimed, Inc.: Key Development

그림 목록 (Figures)

List of Figures

Figure 1 Global Gastric Balloon Procedure Market Share, By Product Type, 2022 & 2031(%)

Figure 2 Global Gastric Balloon Procedure Market Share, By Procedure, 2022 & 2031(%)

Figure 3 Global Gastric Balloon Procedure Market Share, By Filling, 2022 & 2031(%)

Figure 4 Global Gastric Balloon Procedure Market Share, By Volume, 2022 & 2031(%)

Figure 5 Global Gastric Balloon Procedure Market Share, By End-User, 2022 & 2031(%)

Figure 6 Global Gastric Balloon Procedure Market Share, By Region, 2022 & 2031(%)

Figure 7 Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 8 Global Gastric Balloon Procedure Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 9 Single Gastric Balloon: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 10 Dual Gastric Balloon: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 11 Triple Gastric Balloon: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 12 Global Gastric Balloon Procedure Market Y-o-Y Growth, By Procedure, 2022-2031 (%)

Figure 13 Endoscopic: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 14 Non-Endoscopic: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 15 Global Gastric Balloon Procedure Market Y-o-Y Growth, By Filling, 2022-2031 (%)

Figure 16 Saline Filled Gastric Balloon: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 17 Gas Filled Gastric Balloon: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 18 Global Gastric Balloon Procedure Market Y-o-Y Growth, By Volume, 2022-2031 (%)

Figure 19 Adjustable Gastric Balloon: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 20 Non-Adjustable Gastric Balloon: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 21 Global Gastric Balloon Procedure Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 22 Hospitals: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 23 Ambulatory Surgical Centers: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 24 Clinics: Global Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 25 Global Gastric Balloon Procedure Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 26 North America Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 27 North America Gastric Balloon Procedure Market Share, By Product Type, 2022 & 2031(%)

Figure 28 North America Gastric Balloon Procedure Market Share, By Procedure, 2022 & 2031(%)

Figure 29 North America Gastric Balloon Procedure Market Share, By Filling, 2022 & 2031(%)

Figure 30 North America Gastric Balloon Procedure Market Share, By Volume, 2022 & 2031(%)

Figure 31 North America Gastric Balloon Procedure Market Share, By End-User, 2022 & 2031(%)

Figure 32 North America Gastric Balloon Procedure Market Share, By Country, 2022 & 2031(%)

Figure 33 South America Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 34 South America Gastric Balloon Procedure Market Share, By Product Type, 2022 & 2031(%)

Figure 35 South America Gastric Balloon Procedure Market Share, By Procedure, 2022 & 2031(%)

Figure 36 South America Gastric Balloon Procedure Market Share, By Filling, 2022 & 2031(%)

Figure 37 South America Gastric Balloon Procedure Market Share, By Volume, 2022 & 2031(%)

Figure 38 South America Gastric Balloon Procedure Market Share, By End-User, 2022 & 2031(%)

Figure 39 South America Gastric Balloon Procedure Market Share, By Country, 2022 & 2031(%)

Figure 40 Europe Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 41 Europe Gastric Balloon Procedure Market Share, By Product Type, 2022 & 2031(%)

Figure 42 Europe Gastric Balloon Procedure Market Share, By Procedure, 2022 & 2031(%)

Figure 43 Europe Gastric Balloon Procedure Market Share, By Filling, 2022 & 2031(%)

Figure 44 Europe Gastric Balloon Procedure Market Share, By Volume, 2022 & 2031(%)

Figure 45 Europe Gastric Balloon Procedure Market Share, By End-User, 2022 & 2031(%)

Figure 46 Europe Gastric Balloon Procedure Market Share, By Country, 2022 & 2031(%)

Figure 47 Asia-Pacific Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 48 Asia-Pacific Gastric Balloon Procedure Market Share, By Product Type, 2022 & 2031(%)

Figure 49 Asia-Pacific Gastric Balloon Procedure Market Share, By Procedure, 2022 & 2031(%)

Figure 50 Asia-Pacific Gastric Balloon Procedure Market Share, By Filling, 2022 & 2031(%)

Figure 51 Asia-Pacific Gastric Balloon Procedure Market Share, By Volume, 2022 & 2031(%)

Figure 52 Asia-Pacific Gastric Balloon Procedure Market Share, By End-User, 2022 & 2031(%)

Figure 53 Asia-Pacific Gastric Balloon Procedure Market Share, By Country, 2022 & 2031(%)

Figure 54 Middle East & Africa Gastric Balloon Procedure Market Value, 2022-2031 ($ Million)

Figure 55 Middle East & Africa Gastric Balloon Procedure Market Share, By Product Type, 2022 & 2031(%)

Figure 56 Middle East & Africa Gastric Balloon Procedure Market Share, By Procedure, 2022 & 2031(%)

Figure 57 Middle East & Africa Gastric Balloon Procedure Market Share, By Filling, 2022 & 2031(%)

Figure 58 Middle East & Africa Gastric Balloon Procedure Market Share, By Volume, 2022 & 2031(%)

Figure 59 Middle East & Africa Gastric Balloon Procedure Market Share, By End-User, 2022 & 2031(%)

Figure 60 Apollo Endosurgery Inc.: Financials

Figure 61 ReShape Lifesciences, Inc.: Financials

Figure 62 LEXEL S.R.L.: Financials

Figure 63 Medispar C.V.B.A: Financials

Figure 64 Allurion: Financials

Figure 65 Helioscopie Medical Implants: Financials

Figure 66 Districlass Médical: Financials

Figure 67 ENDALIS: Financials

Figure 68 Accel Medical: Financials

Figure 69 Silimed, Inc.: Financials